Supporting our findings, the public database (http://gepia.cancer-pku.cn, accessed on 1 January 2018) revealed that GBM tissue expressed higher levels of CCR5 than normal controls (Figure 6L) and that CCR5 expression was correlated with YKL-40 expression (Figure 6M). The gene discussed is CHI3L1; the disease is glioblastoma.